Exposure to outdoor air pollution may increase the risk of several non-lung cancers. (Harvard T. H. Chan School of Public Health, Environmental Epidemiology)
A physician talks about the shock of learning that she missed the warning signs of her own cancer. (CNN)
The FDA expanded approval of trifluridine and tipiracil (Lonsurf) to include combination therapy with bevacizumab (Avastin) for previously treated metastatic colorectal cancer.
Clonal expansion of a certain type of T cell appears to be the reason that immune checkpoint inhibitors cause arthritis as a side effect in some patients. (Science Immunology)
Syndax and Incyte announced that a pivotal trial of the CSF-1R antibody axatilimab met the primary endpoint of objective response for previously treated graft-versus-host disease.
Diagnosis of early-stage cancers declined sharply during the first year of the COVID-19 pandemic. (American Cancer Society, Lancet Oncology)
Non-Hispanic Black patients have worse outcomes among survivors of second primary cancers. (American Cancer Society, JAMA Network Open)
A new type of clinic for patients with breast cancer offers assistance with legal issues. (Mount Sinai Health System)
Older age, coverage by public health insurance, and a pattern of not attending routine health check-ups identified women in Japan who were less likely to participate in breast cancer screening. (Breast Cancer)
A variety of gastrointestinal symptoms may persist for years in women who survive colorectal cancer. (Ohio State University, PLoS One)
-
Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. He joined MedPage Today in 2007. Follow
Please enable JavaScript to view the